Cystic form of XXXX ( @entity3986 in @entity788 (CDHP)): a potential link with @entity854 ? A study in a large series.

@entity1 @entity788 @entity384 @entity3986 @entity660 @entity730 @entity854 @entity1829 @entity45 @entity1577
OBJECTIVES: To analyze the association between @entity3986 in the @entity1577 . MATERIAL AND METHODS: Seventy-six @entity1 with CDHP were retrospectively included over 14  years. Two radiologists searched for MDCT signs of CDHP (cysts and thickened intestinal wall, inflammatory changes), and @entity854 (Santorini duct dilatation, luminal @entity730 of the @entity1829 ). Other @entity660 (parenchymal @entity730 , main @entity384 ) or bile duct dilatation were also analysed. RESULTS: CDHP was mostly located in the second part of the duodenum (71/76, 93.5  %). Median duodenal wall thickness was 20  mm (range 10-46). There were @entity45 in 86  % (65/76, median   =   3), measuring 2-60  mm. No cysts were identified in four @entity1 (5  %). Inflammatory changes were found in 87  % (66/76). @entity854 were found in 37  % (28/76) and @entity730 without @entity730 in the major papilla were only observed in three @entity1 (4  %). @entity788 and main bile duct dilatation were identified in 78  % (59/76) and 38  % (29/76). CONCLUSION: Previously described CT features were seen in most @entity1 with CDHP. However, @entity854 were seen in a minority of @entity1 and, therefore, do not seem to be a predisposing factor for CDHP. KEY POINTS:     Imaging features suggesting a CDHP diagnosis are confirmed in a large series.     @entity854 do not seem to be a predisposing factor for CDHP.     Most @entity1 did not have any isolated @entity854 .
